Welcome to LookChem.com Sign In|Join Free
  • or
Adenosine, 5'-O-(3-carboxy-2-pyridinyl)-N-[(phenylamino)carbonyl]-2',3'-O-(2-phenyl ethylidene)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

851046-30-5

Post Buying Request

851046-30-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

851046-30-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 851046-30-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,1,0,4 and 6 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 851046-30:
(8*8)+(7*5)+(6*1)+(5*0)+(4*4)+(3*6)+(2*3)+(1*0)=145
145 % 10 = 5
So 851046-30-5 is a valid CAS Registry Number.

851046-30-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-{2-benzyl-6-[6-(3-phenyl-ureido)-purin-9-yl]-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethoxy}-nicotinic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:851046-30-5 SDS

851046-30-5Downstream Products

851046-30-5Relevant academic research and scientific papers

NON-NUCLEOTIDE COMPOSITIONS AND METHOD FOR TREATING PAIN

-

Page/Page column 57, (2008/06/13)

The present invention is directed to a method of treating pain. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a P2X receptor antagonist. The methods of the present invention are useful in reducing pain, such as traumatic pain, neuropathic pain, organ pain and/or pain associated with diseases. The P2X receptor antagonists useful for this invention are non-nucleotide compounds of general Formula I. Compounds of Formula I can be used alone to treat pain. Compounds of Formula I can also be used in conjunction with other therapeutic agents or adjunctive therapies commonly used to treat pain, thus enhancing the therapeutic effect of pain reduction.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 851046-30-5